Qß Virus-like particle-based vaccine induces robust immunity and protects against tauopathy
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Qß Virus-like particle-based vaccine induces robust immunity and protects against tauopathy
Authors
Keywords
-
Journal
npj Vaccines
Volume 4, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-06-03
DOI
10.1038/s41541-019-0118-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Disease-related determinants are associated with mortality in dementia due to Alzheimer’s disease
- (2018) Hanneke F. M. Rhodius-Meester et al. Alzheimers Research & Therapy
- Hepatitis B core VLP-based mis-disordered tau vaccine elicits strong immune response and alleviates cognitive deficits and neuropathology progression in Tau.P301S mouse model of Alzheimer’s disease and frontotemporal dementia
- (2018) Mei Ji et al. Alzheimers Research & Therapy
- B Cells Are the Dominant Antigen-Presenting Cells that Activate Naive CD4+ T Cells upon Immunization with a Virus-Derived Nanoparticle Antigen
- (2018) Sheng Hong et al. IMMUNITY
- Peripheral immune system in aging and Alzheimer’s disease
- (2018) Wei Cao et al. Molecular Neurodegeneration
- Ten Years of Tau-Targeted Immunotherapy: The Path Walked and the Roads Ahead
- (2018) Petr Novak et al. Frontiers in Neuroscience
- Safety and immunogenicity of the tau vaccine AADvac1 in patients with Alzheimer's disease: a randomised, double-blind, placebo-controlled, phase 1 trial
- (2017) Petr Novak et al. LANCET NEUROLOGY
- Major findings and recent advances in virus–like particle (VLP)-based vaccines
- (2017) Mona O. Mohsen et al. SEMINARS IN IMMUNOLOGY
- Aβ-amyloid and Tau Imaging in Dementia
- (2017) Victor L. Villemagne et al. SEMINARS IN NUCLEAR MEDICINE
- Imaging the accumulation and suppression of tau pathology using multiparametric MRI
- (2016) Holly E. Holmes et al. NEUROBIOLOGY OF AGING
- PET Imaging of Tau Deposition in the Aging Human Brain
- (2016) Michael Schöll et al. NEURON
- Reactive microglia drive tau pathology and contribute to the spreading of pathological tau in the brain
- (2015) Nicole Maphis et al. BRAIN
- In vivo imaging of tau pathology using multi-parametric quantitative MRI
- (2015) J.A. Wells et al. NEUROIMAGE
- A cholesterol-lowering VLP vaccine that targets PCSK9
- (2015) Erin Crossey et al. VACCINE
- Sensitivity to change and prediction of global change for the Alzheimer’s Questionnaire
- (2015) Michael Malek-Ahmadi et al. Alzheimers Research & Therapy
- Neuronal uptake of tau/pS422 antibody and reduced progression of tau pathology in a mouse model of Alzheimer‘s disease
- (2014) Ludovic Collin et al. BRAIN
- Tau-targeting passive immunization modulates aspects of pathology in tau transgenic mice
- (2014) Arne Ittner et al. JOURNAL OF NEUROCHEMISTRY
- Passive Immunization with Tau Oligomer Monoclonal Antibody Reverses Tauopathy Phenotypes without Affecting Hyperphosphorylated Neurofibrillary Tangles
- (2014) D. L. Castillo-Carranza et al. JOURNAL OF NEUROSCIENCE
- Open questions for Alzheimer’s disease immunotherapy
- (2014) Todd E Golde Alzheimers Research & Therapy
- First-in-man tau vaccine targeting structural determinants essential for pathological tau–tau interaction reduces tau oligomerisation and neurofibrillary degeneration in an Alzheimer’s disease model
- (2014) Eva Kontsekova et al. Alzheimers Research & Therapy
- Clinicopathologic assessment and imaging of tauopathies in neurodegenerative dementias
- (2014) Melissa E Murray et al. Alzheimers Research & Therapy
- Repeated immunization of mice with phosphorylated-tau peptides causes neuroinflammation
- (2013) Lea Rozenstein-Tsalkovich et al. EXPERIMENTAL NEUROLOGY
- Antibody Uptake into Neurons Occurs Primarily via Clathrin-dependent Fcγ Receptor Endocytosis and Is a Prerequisite for Acute Tau Protein Clearance
- (2013) Erin E. Congdon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Two Novel Tau Antibodies Targeting the 396/404 Region Are Primarily Taken Up by Neurons and Reduce Tau Protein Pathology
- (2013) Jiaping Gu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Antibody Drug Absorption Following Subcutaneous or Intramuscular Administration and Its Mathematical Description by Coupling Physiologically Based Absorption Process with the Conventional Compartment Pharmacokinetic Model
- (2013) Liang Zhao et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Age-related decline in white matter integrity in a mouse model of tauopathy: an in vivo diffusion tensor magnetic resonance imaging study
- (2013) Naruhiko Sahara et al. NEUROBIOLOGY OF AGING
- Microglial derived tumor necrosis factor-α drives Alzheimer's disease-related neuronal cell cycle events
- (2013) Kiran Bhaskar et al. NEUROBIOLOGY OF DISEASE
- Anti-Tau Antibodies that Block Tau Aggregate Seeding In Vitro Markedly Decrease Pathology and Improve Cognition In Vivo
- (2013) Kiran Yanamandra et al. NEURON
- Developing Therapeutic Antibodies for Neurodegenerative Disease
- (2013) Y. Joy Yu et al. Neurotherapeutics
- National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease
- (2012) Bradley T. Hyman et al. Alzheimers & Dementia
- Immunogenicity to Biologics: Mechanisms, Prediction and Reduction
- (2012) Swaminathan Sethu et al. ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS
- Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature
- (2012) Peter T. Nelson et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: Recommendations from the Alzheimer’s Association Research Roundtable Workgroup
- (2011) Reisa A. Sperling et al. Alzheimers & Dementia
- Passive immunization targeting pathological phospho-tau protein in a mouse model reduces functional decline and clears tau aggregates from the brain
- (2011) Allal Boutajangout et al. JOURNAL OF NEUROCHEMISTRY
- Stages of the Pathologic Process in Alzheimer Disease: Age Categories From 1 to 100 Years
- (2011) Heiko Braak et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- The Second-Generation Active A Immunotherapy CAD106 Reduces Amyloid Accumulation in APP Transgenic Mice While Minimizing Potential Side Effects
- (2011) C. Wiessner et al. JOURNAL OF NEUROSCIENCE
- Mechanistic Studies of Antibody-Mediated Clearance of Tau Aggregates Using an ex vivo Brain Slice Model
- (2011) Pavan K. Krishnamurthy et al. Frontiers in Psychiatry
- Virus-like Peptide Vaccines Against Aß N-terminal or C-Terminal Domains Reduce Amyloid Deposition in APP Transgenic Mice without Addition of Adjuvant
- (2010) Qing-you Li et al. Journal of Neuroimmune Pharmacology
- Immunotherapy Targeting Pathological Tau Prevents Cognitive Decline in a New Tangle Mouse Model
- (2010) A. Boutajangout et al. JOURNAL OF NEUROSCIENCE
- The safety and side effects of monoclonal antibodies
- (2010) Trevor T. Hansel et al. NATURE REVIEWS DRUG DISCOVERY
- Regulation of Tau Pathology by the Microglial Fractalkine Receptor
- (2010) Kiran Bhaskar et al. NEURON
- Virus-like particle vaccine activates conventional B2 cells and promotes B cell differentiation to IgG2a producing plasma cells
- (2009) Sheng Zhang et al. MOLECULAR IMMUNOLOGY
- Sex difference in pathology and memory decline in rTg4510 mouse model of tauopathy
- (2009) Mei Yue et al. NEUROBIOLOGY OF AGING
- Immunodrugs: Therapeutic VLP-Based Vaccines for Chronic Diseases
- (2008) Gary T. Jennings et al. Annual Review of Pharmacology and Toxicology
- Neuropathology and Cognitive Impairment in Alzheimer Disease: A Complex but Coherent Relationship
- (2008) Peter T. Nelson et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started